RPG Life Sciences Limited
Records under this name other than patents RPG Life Sciences Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to RPG Life Sciences Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,428,461 | Process for the preparation of a benzazepine derivative Lapsed on the fee record Ended Aug 30, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2020 | From the USPTO record |
| US 8,063,217 | Process for preparation of methyl-(+)-(S)-alpha-(2-chlorophenyl)-6, 7-dihydrothieno[3,2-C]pyridine-5(4H) -acetic acid methyl ester or salts thereof having higher chiral purity and products thereof Lapsed on the fee record Ended Nov 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2019 | From the USPTO record |
| US 6,897,308 | Process for the preparation of anti-psychotic 3-[2-[-4-(6-fluoro-1,2-benziosoxazol-3-yl)-1-piperidinyl] ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one Lapsed on the fee record Ended May 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2017 | From the USPTO record |
| US 6,639,072 | Process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine Lapsed on the fee record Ended Oct 28, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2015 | From the USPTO record |
| US 7,056,530 | Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities Lapsed on the fee record Ended Jun 6, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2014 | From the USPTO record |